ASCO Report: National Survey Reveals Most Americans Are Unaware of Key Cancer Risk Factors
ASCO released its first annual National Cancer Opinion Survey this week. Survey reveals low awareness of key cancer risk factors among other key findings. Click on image to see full report. See full report at: https://www.asco.org/advocacy-policy/asco-in-action/national-survey-reveals-most-americans-are-unaware-key-cancer-risk?et_cid=39719969&et_rid=913722420&linkid=Read+More+
Cancer clinical trials in KS and MO: Bringing Hope to Patients
KC Business Journal Health Report Elise Reuter highlights the cancer clinical trials work ongoing in our local area. http://media.bizj.us/view/img/10658374/clinicaltrials*xx.jpg
ASCO: Disparities of Cancer
The National Cancer Institute defines cancer health disparities as “adverse differences in cancer incidence (new cases), cancer prevalence (all existing cases), morbidity (cancer-related health complications), cancer mortality (deaths), cancer survivorship, and burden of cancer or related health conditions that exist among specific population groups in the United States.”1 See Full ASCO Brief to better understand this critical issue in cancer treatment. Click on image for mor
Speed to Market: Where is the evidence for EU oncology approvals?
Recent BMJ review looks at the data on oncology drugs approved in the EU from 2009-2013 to assess the overall survival and quality of life benefits. The analysis sparks the debate on whether newer regulatory pathways which attempt to get potentially life saving drugs into the hands of oncologists is at the cost of approving drugs with minimal benefit. Click on image above to go to BMJ article and listen to podcast.